BeStock  
Stocks › Biotechnology › BLTE

Belite Bio BLTE

US equityMarket cap rank #2018Biotechnology
$127.38 −$23.64 (-15.65%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $127.38 0.00%
Open$129.00
Prev close$151.02
Day range$120.00 – $135.07
Volume1.04M
Market cap$5.17B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts6
Average target$231.67+81.9% vs. price
  • Buy 100%
Low $200.00Now $127.38Avg $231.67High $303.00

Recent rating changes

The last 20 actions on file set price targets from $200.00 to $303.00, averaging $230.95.

DateFirmRatingTarget
13 Nov 2026 Leerink Partners BUY $215.00
13 Nov 2026 H.C. Wainwright BUY $245.00
29 Oct 2026 Mizuho Securities BUY $221.00
15 Oct 2026 H.C. Wainwright BUY $245.00
9 Sep 2026 Mizuho Securities BUY $234.00
9 Sep 2026 H.C. Wainwright BUY $245.00
8 Sep 2026 H.C. Wainwright BUY $245.00
4 Sep 2026 CCORF BUY $303.00
4 Sep 2026 Mizuho Securities BUY $220.00
3 Sep 2026 H.C. Wainwright BUY $214.00
2 Sep 2026 BofA Securities BUY $200.00
31 Aug 2026 Mizuho Securities BUY $220.00
17 Aug 2026 Morgan Stanley BUY $206.00
14 Aug 2026 Cantor Fitzgerald BUY $270.00
14 Aug 2026 Mizuho Securities BUY $220.00
14 Aug 2026 Maxim Group BUY $200.00
14 Aug 2026 BofA Securities BUY –
14 Aug 2026 Morgan Stanley BUY $201.00
14 Aug 2026 H.C. Wainwright BUY $214.00
13 Aug 2026 Cantor Fitzgerald BUY $270.00

Discussion

No comments yet — be the first to weigh in on BLTE.

Sign in to join the discussion.

Scroll to Top